Furthermore, preclinical and clinical studies indicate that sTREM2 may exert neuroprotective effects by mitigating Aβ and tau pathologies, potentially slowing cognitive decline and disease progression [20–23]. This evidence concerns the gene MAPT and Mental deterioration.